What happens when you take CBD with cyclosporine?
Cyclosporine (Neoral, Sandimmune, Gengraf) is an immunosuppressant used to prevent rejection after kidney, liver and heart transplants, and Neoral is also used for severe rheumatoid arthritis and psoriasis. It is dosed by blood level because the safe range is narrow. CBD (cannabidiol) is sold as oils, gummies and capsules for pain, sleep and anxiety. CBD can raise blood levels of drugs that cyclosporine resembles in how the body handles them.
- Cyclosporine is broken down mainly by CYP3A4 and is pumped by the P-glycoprotein (P-gp) transporter, according to its label.
- The Epidiolex label warns that CBD may increase exposure to drugs taken by mouth that depend on P-gp, naming sirolimus, tacrolimus and digoxin.
- In healthy adults, prescription CBD raised exposure to everolimus, a transplant drug handled by both P-gp and CYP3A4, about 2.5-fold.
- In the same label, CBD did not change levels of midazolam, a drug used to test CYP3A4, so the label points to the P-gp route. Cyclosporine is also a P-gp substrate, so its levels may rise too. A case report in a kidney transplant recipient described such an interaction, but its size has not been measured.
Why is this important?
A rise in cyclosporine levels can increase the risk of kidney damage and other toxicity, which the cyclosporine labels describe. Stopping CBD after a dose has been adjusted could have the opposite effect and let levels fall.
Consumer CBD products vary in strength, and the studies behind the Epidiolex warning used prescription doses. How much a typical consumer product affects cyclosporine is not known, which is a reason to involve your team rather than a reason for reassurance.
For tacrolimus, a related transplant drug, a study in 12 healthy adults (So GC, et al. Clin Pharmacol Ther. 2025) found that high-dose CBD raised exposure about threefold. Cyclosporine has not been studied the same way.
What should you do?
The principle: treat any start, stop or change in a CBD product as a medication change, and tell your team first.
Before starting: Check product labels for CBD, cannabidiol, hemp extract or full-spectrum hemp. Ask your transplant team or prescriber before using any of them.
Every day while on cyclosporine: Take cyclosporine exactly as prescribed and keep your blood-level tests. Keep using the same CBD product only if your team knows about it.
After a change: If you have been using CBD, tell your team rather than stopping on your own, so they can decide whether to check your level.
Which specific products are affected?
On the medication side, this applies to oral cyclosporine: Neoral, Sandimmune, Gengraf and generic cyclosporine capsules and oral solution. Cyclosporine eye drops (such as Restasis) are applied to the eye rather than swallowed and were not part of these sources; mention them to your clinician anyway.
On the CBD side, it covers prescription Epidiolex and consumer CBD oils, tinctures, gummies, capsules and drinks, including products labeled hemp extract or full-spectrum hemp. Topical CBD was not part of these sources.
The science behind it
The Epidiolex label (section 7.2) says increases in exposure of orally administered P-gp substrates such as sirolimus, tacrolimus and digoxin may be observed with CBD, and advises therapeutic drug monitoring and dose reduction. Its section 12.3 reports that CBD raised everolimus peak level and AUC about 2.5-fold in healthy subjects, and did not change levels of the CYP3A4 test drug midazolam. The Neoral label states that cyclosporine is extensively metabolized by CYP3A4 and is a P-glycoprotein substrate.
A case report (Cuñetti L, et al. Transplant Proc. 2024) described a pharmacokinetic interaction between CBD, cyclosporine and mycophenolate in a kidney transplant recipient and advised monitoring drug levels; the abstract does not report the size of the change. A 2014 review (Colombo D, et al. J Toxicol.) notes that CBD increased cyclosporine levels in animal studies.
What has not been shown: there is no controlled study of CBD with cyclosporine in people, and no data on typical consumer CBD amounts. One case report is a signal, not proof.
Frequently Asked Questions
Can I use CBD oil while on cyclosporine?
Ask your transplant team or prescriber first. CBD may raise cyclosporine levels, and your team may want to check your level.
Is a low-dose CBD gummy a problem?
Nobody knows how much a small consumer dose affects cyclosporine. The label warning is based on prescription doses, so involve your team either way.
Does hemp extract count as CBD?
Often, yes. Many products list CBD as hemp extract or full-spectrum hemp, so check the label.
What if I have been using CBD for a while?
Tell your team rather than stopping on your own. Your current level may already reflect the CBD, and stopping could change it.
Is CBD cream a concern?
Topical CBD was not part of these sources. Mention it to your team so they have the full picture.
Key takeaways
- CBD can raise levels of oral drugs handled by the P-gp transporter, and cyclosporine is one of them.
- The Epidiolex label advises drug-level monitoring and dose reduction for P-gp substrates such as tacrolimus and sirolimus.
- One case report described a CBD and cyclosporine interaction in a kidney transplant recipient; its size is unknown.
- Labels may say hemp extract or full-spectrum hemp instead of CBD.
- Treat any start, stop or change in CBD as a medication change and tell your team first.
